Key result
nMARQ multielectrode catheter achieves ~99% acute PVI with favorable mid-term freedom from AF.
Why the study?
Does the nMARQ circular irrigated multielectrode ablation catheter safely and effectively achieve pulmonary vein isolation in patients with drug-refractory paroxysmal atrial fibrillation?
Cohort (n=35)
Yes
Does the nMARQ circular irrigated multielectrode ablation catheter safely and effectively achieve pulmonary vein isolation in patients with drug-refractory paroxysmal atrial fibrillation?
Answers are grounded in this paper and cite their sources.
The nMARQ multielectrode ablation catheter demonstrates high acute pulmonary vein isolation rates and good midterm efficacy for paroxysmal AF, although careful manipulation is required to avoid tissue damage.
BACKGROUND: PV electrical isolation has become the cornerstone of catheter ablation for the treatment of atrial fibrillation (AF). Several strategies have been proposed to achieve this goal. The aim of this study was to assess the efficacy and safety of AF ablation using a new circular irrigated multielectrode ablation catheter designed to achieve single-delivery pulmonary vein (PV) isolation. METHODS: Thirty-five patients with drug refractory paroxysmal AF and normal ejection fraction from two centers were prospectively enrolled in this study. All patients underwent PV isolation with an nMARQ circular irrigated multielectrode ablation catheter guided by an electroanatomic mapping system. Magnetic resonance imaging was performed to exclude PV stenosis. RESULTS: PV isolation was achieved in 138 of 140 (98.57%) targeted veins. The mean procedure time was 79.5 min (SD 39.3 min). During a mean follow up of 16.8±2.8 months, 27 of 35 (77.2%) patients were free of AF. No PV narrowing was observed. One case of pericardial effusion due to perforation of the left atrial free wall during catheter manipulation did occur. CONCLUSIONS: PV isolation with a circular irrigated multielectrode ablation catheter is a feasible technique with a high acute success rate. The majority of patients remained asymptomatic during the midterm follow-up period. PV stenosis was not detected. While only a single serious adverse event occurred, this technique׳s safety profile should be tested in larger studies.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐Entem et al. (2015) conducted a cohort in Drug-refractory paroxysmal atrial fibrillation (n=35). nMARQ circular irrigated multielectrode ablation catheter was evaluated on Acute isolation rate of targeted pulmonary veins (98.57% (138 of 140 targeted veins)). The nMARQ circular irrigated multielectrode ablation catheter achieved acute pulmonary vein isolation in 98.57% of targeted veins, with 77.2% of patients free of AF at 16.8 months follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: